Anti-endoglin mediated modulation of intratumoral Immune Cell Subpopulationg in vivo and effect of combination treatment with anti-PD1 monoclonal antibodies
Research Grant
Administered By
Duke Cancer Institute
Awarded By
Tracon Pharmaceuticals, Inc.
Start Date
September 11, 2015
End Date
September 11, 2017
Administered By
Duke Cancer Institute
Awarded By
Tracon Pharmaceuticals, Inc.
Start Date
September 11, 2015
End Date
September 11, 2017